News Image

Tonix Pharmaceuticals Announces Oral Presentation on Mpox and Smallpox vaccine candidate TNX-801 at the Vaccine Congress 2025

Provided By GlobeNewswire

Last update: Jul 7, 2025

Single dose vaccination with TNX-801 protects animals from a lethal challenge with monkeypox, the causative agent of mpox

TNX-801 confers durable protection after a single dose

Read more at globenewswire.com

TONIX PHARMACEUTICALS HOLDIN

NASDAQ:TNXP (7/21/2025, 8:00:01 PM)

After market: 45.55 +0.45 (+1%)

45.1

-1.81 (-3.86%)



Find more stocks in the Stock Screener

Follow ChartMill for more